Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Standard Dose
EQ 0.083% BASE;0.017%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 207875 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Sponsor SUN PHARM Submission history Latest submission status date: 2025-02-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 207875 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Sponsor SUN PHARM Submission history Latest submission status date: 2025-02-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (ALBUTEROL SULFATE; IPRATROPIUM BROMIDE) | Drug Monograph | MedicHelpline